CSI Market
Sign In | Register

Denali Therapeutics Inc (DNLI) Annual Balance Sheets

Annual · GAAP · USD millions
Access DNLI quarterly Balance Sheets →
Balance sheet data covering Denali Therapeutics Inc–Dec 31 2021 offers a view into how Dec 31 2025's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent205.33
Marketable Securities, Current SH662.55
Cash & Short-term Investments867.00
Due from Related Parties, Current RE0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current32.78
Total Current Assets900.66
Equipment/Property/Plant Net52.40
Long-term investments98.32
Other Assets, Noncurrent191.79
Operating Lease Right Of Use Asset19.00
Total Assets1,144.85
Liabilities
Accounts Payable, Current AC3.33
Accrued Liabilities, Current AC95.02
Other Liabilities, Current0.00
Total Current Liabilities98.35
Total Long-term Debt0.00
Other liabilities, Noncurrent32.74
OperatingLeaseLiabilityNoncurrent27.21
Other Accrued Manufacturing Costs Current-
Contract With Customer Liability Noncurrent-
Total Liabilities131.09
Stockholders' Equity
Common Stock Value1.89
Additional Paid In Capital Common Stock3,062.72
Retained Earnings / Accumulated Deficit-2,051.52
Other Equity0.68
Common Stockholder's Equity1,013.76
Total Stockholder's Equity1,013.76
Liabilities & Stockholder's Equity1,144.85
4 historic quarters locked

Sign in to unlock the full Denali Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Denali Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: dnli-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001714899-26-000021

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License